Phio Pharmaceuticals Corp. (PHIO)

SEC filing

Phio Pharmaceuticals Corp.

PHIO · CIK 1533040

4 · Sep 23, 2026 · Director, Chairman, Pres. & CEO Bitterman Robert J bought 2,000 Common Stock, $.0001 par value at $1.03/unit ($2,058)

Director, Chairman, Pres. & CEO Bitterman Robert J bought 2,000 Common Stock, $.0001 par value at $1.03/unit ($2,058)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).